GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngen Biotech Co Ltd (ROCO:8279) » Definitions » Cyclically Adjusted FCF per Share

Syngen Biotech Co (ROCO:8279) Cyclically Adjusted FCF per Share : NT$1.28 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Syngen Biotech Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Syngen Biotech Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was NT$0.783. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$1.28 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-25), Syngen Biotech Co's current stock price is NT$161.00. Syngen Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was NT$1.28. Syngen Biotech Co's Cyclically Adjusted Price-to-FCF of today is 125.78.

During the past 12 years, the highest Cyclically Adjusted Price-to-FCF of Syngen Biotech Co was 204.22. The lowest was 117.19. And the median was 125.62.


Syngen Biotech Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Syngen Biotech Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngen Biotech Co Cyclically Adjusted FCF per Share Chart

Syngen Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.21

Syngen Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.83 1.21 1.28

Competitive Comparison of Syngen Biotech Co's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Syngen Biotech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngen Biotech Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngen Biotech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Syngen Biotech Co's Cyclically Adjusted Price-to-FCF falls into.



Syngen Biotech Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Syngen Biotech Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.783/131.7762*131.7762
=0.783

Current CPI (Mar. 2024) = 131.7762.

Syngen Biotech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 0.000 98.326 0.000
201406 0.000 100.560 0.000
201412 0.000 99.070 0.000
201503 1.161 99.621 1.536
201506 0.423 100.684 0.554
201509 1.573 100.392 2.065
201512 -1.451 99.792 -1.916
201603 0.698 100.470 0.915
201606 -0.163 101.688 -0.211
201609 1.926 101.861 2.492
201612 -1.876 101.863 -2.427
201703 -8.212 102.862 -10.520
201706 0.963 103.349 1.228
201709 0.244 104.136 0.309
201712 1.273 104.011 1.613
201803 0.189 105.290 0.237
201806 -2.991 106.317 -3.707
201809 0.692 106.507 0.856
201812 1.001 105.998 1.244
201903 3.748 107.251 4.605
201906 -1.800 108.070 -2.195
201909 2.407 108.329 2.928
201912 1.782 108.420 2.166
202003 -2.468 108.902 -2.986
202006 -1.987 108.767 -2.407
202009 -2.414 109.815 -2.897
202012 4.925 109.897 5.906
202103 2.259 111.754 2.664
202106 -1.956 114.631 -2.249
202109 5.353 115.734 6.095
202112 4.486 117.630 5.026
202203 0.441 121.301 0.479
202206 -21.110 125.017 -22.251
202209 6.694 125.227 7.044
202212 2.654 125.222 2.793
202303 3.018 127.348 3.123
202306 -1.785 128.729 -1.827
202309 6.946 129.860 7.049
202312 3.673 129.419 3.740
202403 0.783 131.776 0.783

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Syngen Biotech Co  (ROCO:8279) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Syngen Biotech Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=161.00/1.28
=125.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted Price-to-FCF of Syngen Biotech Co was 204.22. The lowest was 117.19. And the median was 125.62.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Syngen Biotech Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Syngen Biotech Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngen Biotech Co (ROCO:8279) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.

Syngen Biotech Co (ROCO:8279) Headlines

No Headlines